SEP 17, 2018 8:20 AM PDT

Daily Low-Dose Aspirin Not Effective In Prolonging Health

WRITTEN BY: Nouran Amin

A recent research study, published in The New England Journal of Medicine, found that the daily low-dose aspirin held no effects in healthy older adults. "Clinical guidelines note the benefits of aspirin for preventing heart attacks and strokes in persons with vascular conditions such as coronary artery disease," said NIA Director Richard J. Hodes, M.D. "The concern has been uncertainty about whether aspirin is beneficial for otherwise healthy older people without those conditions. This study shows why it is so important to conduct this type of research so that we can gain a fuller picture of aspirin's benefits and risks among healthy older persons."

The study began in 2010 and enrolled participants aged 70 and older with 65 being the minimum age of entry for African-American and Hispanic individuals in the United States due to their increased their risk of dementia and cardiovascular disease. At the time of enrolment in the study, participants must have been free from dementia, physical disability, and any other medical conditions requiring aspirin use. Furthermore, each participant was placed on a follow-up for an average of 4.7 years to determine outcomes. They were followed for an average of 4.7 years to determine outcomes. It was later found that these participants treated with 100 mg of low-dose aspirin daily have not improved the survival free of dementia or disability. The rates of physical disability and dementia were almost identical in the group that did not receive the daily low-dose aspirin as well as the rates of major cardiovascular events, such as coronary heart disease, nonfatal heart attacks, and fatal and nonfatal ischemic stroke.

Low dose aspirin. Credit: © elvis901 / Fotolia

The study also found a risk of significant bleeding with aspirin use as well as an increased risk of death from cancer. "The increase in cancer deaths in study participants in the aspirin group was surprising, given prior studies suggesting aspirin use improved cancer outcomes," explains Leslie Ford, M.D., associate director for clinical research, NCI Division of Cancer Prevention. "Analysis of all the cancer-related data from the trial is underway and until we have additional data, these findings should be interpreted with caution."

 

"These initial findings will help to clarify the role of aspirin in disease prevention for older adults, but much more needs to be learned,” says Evan Hadley, M.D., director of NIA's Division of Geriatrics and Clinical Gerontology.

Source: National Institute on Aging

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 20, 2020
Genetics & Genomics
A Repurposed Drug Can Treat a Genetic Disorder
DEC 20, 2020
A Repurposed Drug Can Treat a Genetic Disorder
Some researchers have sought to treat genetic diseases by correcting the mutation. But it may be possible to use another ...
DEC 20, 2020
Microbiology
How Do mRNA Vaccines Work?
DEC 20, 2020
How Do mRNA Vaccines Work?
Scientist Katalin Karikó studied mRNA vaccines for years. She spent years getting grant rejections, but has now helped c ...
DEC 23, 2020
Clinical & Molecular DX
Smartphone Device Uses CRISPR to Check for COVID
DEC 23, 2020
Smartphone Device Uses CRISPR to Check for COVID
Quick, portable, and ultrasensitive—a new smartphone test for COVID-19 checks all the boxes needed to get a handle ...
JAN 07, 2021
Health & Medicine
How Cannabis Might Help Fibromyalgia
JAN 07, 2021
How Cannabis Might Help Fibromyalgia
Fibromyalgia affects as many as 4 million adults in America  (2 percent of the adult population) and is a debilitat ...
JAN 22, 2021
Clinical & Molecular DX
Breast Cancer's Nasty Nine Revealed
JAN 22, 2021
Breast Cancer's Nasty Nine Revealed
Calculating an individual’s risk of developing breast cancer isn’t easy. There’s a complex interplay b ...
JAN 23, 2021
Microbiology
Host Vouchering & How Can It Improve Pandemic Response
JAN 23, 2021
Host Vouchering & How Can It Improve Pandemic Response
About a year ago, I wrote about the virus that would come to be known as SARS-CoV-2 for the first time. And while we've ...
Loading Comments...